ABBOTT PARK, Ill., Sept. 13 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT - News) announced today CE Mark approval and European launch of the company’s next- generation embolic protection device, the Emboshield® PRO Embolic Protection System. Embolic protection devices are designed to capture and remove particles of atherosclerotic plaque that can become dislodged during a carotid artery stenting procedure, potentially leading to stroke and other complications.
